Washington, Nov. 15 (SANA) Researchers at Johns Hopkins University in the United States have identified changes in two brain regions that may serve as early indicators of Alzheimer’s disease, potentially appearing five to 10 years before clinical symptoms emerge.
ScienceDaily reported Saturday that a study published in September in the journal NeuroImage Reports found that the entorhinal cortex and amygdala begin losing tissue during the early stages of the disease, even before clear changes appear in the hippocampus, which has traditionally received considerable attention in research into brain changes associated with Alzheimer’s.
The researchers analyzed hundreds of brain scans obtained through magnetic resonance imaging (MRI) and positron emission tomography (PET). Their analysis drew on data from two independent research initiatives: the Alzheimer’s Disease Neuroimaging Initiative and the Biomarkers of Cognitive Decline Among Healthy Individuals study.
The findings showed that tissue loss in the entorhinal cortex and amygdala was greater during the early stages of the disease than in the hippocampus. The two regions have different but important functions: the entorhinal cortex contributes to memory retrieval, while the amygdala plays a central role in processing emotions and forming memories linked to emotional experiences.
The team also found an association between tissue shrinkage in these regions and abnormal changes in tau protein. The accumulation of tau can lead to the formation of tangles that interfere with nerve cell function and are among the characteristic features of Alzheimer’s disease.
To examine this relationship, researchers combined PET scan data with analyses of brain tissue. They found an overlap between areas showing gray matter loss and regions displaying changes associated with tau protein.
Lead researcher Michael Miller, a biomedical engineering specialist, said the changes could be detected five to 10 years before clinical symptoms appear. This could create opportunities to investigate interventions at earlier stages, before extensive damage to the brain develops.
Marilyn Albert, a co-author of the study and director of the Alzheimer’s Disease Research Center at Johns Hopkins University, said identifying people at higher risk before symptoms emerge could help delay the disease’s progression or reduce its effects.
The researchers said that assessing changes in both the entorhinal cortex and amygdala could provide additional indicators for detecting early stages of Alzheimer’s, complementing approaches that rely primarily on examining the hippocampus.
However, the findings remain at the research stage and have not established that changes in these regions can be used as a routine diagnostic test. Further studies are needed to determine the accuracy of these indicators, clarify the molecular changes associated with tau protein and assess their potential role in developing early detection methods.
Alzheimer’s is a progressive neurological disease and the most common cause of dementia. It affects memory, thinking and other cognitive abilities, and can gradually impair a person’s ability to carry out everyday activities.
R.H/R.K